Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Which Has Lower Expense Ratio Index Fund Vs Target Date Retirement reviews typical expense differences and practical picks.
28,359 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
GitLab posted its Q4 FY2026 results after the bell, showing revenue and earnings that set the stage for 2027. Stocks ...
The U.S. temporarily eases sanctions on Russian oil loaded on tankers for 30 days, aiming to calm markets amid Middle...
Foreclosures surged to a six-year high in Q1 as insurance and property tax costs squeeze homeowners. Attom data show ...
Market pullbacks can wipe out gains, but some AI leaders actually gain momentum as fear rises. Learn how to spot a st...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
A Harvard professor challenges the eight-hour sleep rule, arguing seven hours may be healthier for many adults. The d...
When a CEO sells a sizable block of stock, investors take notice. This article breaks down the numbers behind imax so...
When TPB releases its Q1 2026 numbers, the 2026 earnings call transcript becomes a treasure map for investors. This g...
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
A family facing lead exposure is told to pause debt payoff to fix a hazardous home, highlighting the clash between he...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...